Capsid assembly modulator dosing regimen

The present disclosure is directed to methods of using a capsid assembly inhibitor for the treatment of hepatitis B virus infection.

Saved in:
Bibliographic Details
Main Authors BALMAIN, Claire Elisabeth, SNOEYS, Jan, VERSTRAETE, Dominique Josiane W, JANSENS, Maria, VANDENBOSSCHE, Joris Jozef, VANDYCK, Koen, VAN DYCKE, Frederic, LENZ, Oliver, YOGARATNAM, Jeysen Zivan
Format Patent
LanguageEnglish
Published 03.09.2020
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present disclosure is directed to methods of using a capsid assembly inhibitor for the treatment of hepatitis B virus infection.
Bibliography:Application Number: AU20190235522